
<DOC>
<DOCNO>WT03-B24-215</DOCNO>
<DOCOLDNO>IA064-000378-B003-229</DOCOLDNO>
<DOCHDR>
http://www.sosei.com:80/PressNews/soseipr1.html 206.86.52.80 19970112095556 text/html 2937
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 09:56:03 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 2755
Last-modified: Fri, 24 May 1996 03:09:01 GMT
</DOCHDR>
<HTML><BODY BGCOLOR=#FFFFFF>For Immediate Release<P>

<A HREF="../Companies/sosei.html">SOSEI CO., LTD.</A> APPOINTS PROFESSOR BARUCH S. BLUMBERG,
A NOBEL PRIZE LAUREATE, TO BOARD DIRECTOR AND SCIENTIFIC ADVISOR<P>

TOKYO -- JUNE, 1995 --<A HREF="../Companies/sosei.html">Sosei Co., Ltd.</A> today announced the appointment of Professor Baruch S. Blumberg who discovered the Hepatitis B Virus, and with his colleague Irring Millman invented the hepatitis B Crossing, to the position of Board Director and Scientific Advisor.<P>

	Professor Blumberg spent his career in medicine and was the Master of Balliol College at Oxford University from 1989 to 1994, currently has an appointments at the Fox Chase Cancer Center in Philadelphia, Pennsylvania. Professor Blumberg has been awarded several scientific prizes including the Nobel Prize for Physiology and Medicine for 1976. Other prizes were Modern Medicine Disting. Achievement award, Internat. award Gairdner Found., Karl Landsteiner Meml. award of the Am. Assn. Blood Banks and others. He is a Fellow Nat. Acad. Scis., Royal Coll. Physicians' mem, Assn. Am. Physicians, Am. Soc. Clin. Investigation mem., Am. Soc. Human Genetics mem. etc.<P>

 	"We are pleased and extremely fortunate to have Professor Blumberg join <A HREF="../Companies/sosei.html">Sosei</A>," commented Mr. Tamura, <A HREF="../Companies/sosei.html">Sosei's</A> President and CEO. "He brings with him the operational skills and strategic talent in research and development needed to bring our company and products into the pharmaceutical market. He will advise in the biopharmaceutical field, especially our original projects in liver disease including the Hepatocyte Growth Factor, at <A HREF="../Companies/sosei.html">Sosei</A>."<P>

     	<A HREF="../Companies/sosei.html">Sosei's</A> desire is to become the most reliable "cultural interpreter" between innovative biotech firms in the U.S./Europe and medical and pharmaceutical companies and research labs in Japan by;<P>

1. Accessing novel biopharmaceutical science in Japan by expediting the licensing and commercialization of university discovered technologies.<BR>
2. Developing strategic licensing arrangements with such science both inside and outside Japan.<BR>
3. Providing the most reliable platform in Japan for small biotech firms in the U.S. and Europe looking for Japanese corporate patners to establish the most efficient global R&D strategy.<P>

<A HREF = "http://www.sosei.com/"><IMG  Align=Middle SRC="../Graphics/home_button.gif"></A><A HREF = "http://www.sosei.com/">  Home Page</A><P>
<HR></BODY>
<ADDRESS><FONT SIZE=3>
Updated June 16, 1995.
Copyright &copy; 1995 <A HREF = "http://www.genweb.com/">GenWeb</A>.
All rights reserved.</FONT></ADDRESS>
</HTML>
</DOC>